Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Pediatric Endocrinology · Congenital Lipoid Adrenal Hyperplasia due to STAR Deficiency

Understanding Your Child's Diagnosis: STAR Deficiency

At a Glance

STAR deficiency, also called congenital lipoid adrenal hyperplasia, is a rare inherited condition in which the body cannot move cholesterol into adrenal cells to make key hormones. Lifelong hormone replacement and specialist monitoring can support a child's growth, development, and active life.

The diagnosis of Congenital Lipoid Adrenal Hyperplasia (LCAH) often arrives in a moment of crisis, potentially following weeks or months of searching for answers [1][2]. For many parents, the initial feeling is a profound sense of shock, often mixed with relief that the “diagnostic odyssey”—the long, exhausting search for a name for your child’s symptoms—has finally ended [3].

You are likely processing a vast amount of information while managing the immediate medical needs of your child. It is important to know that while this condition is complex, it is manageable with a dedicated care team and the right information.

What is STAR Deficiency?

At its simplest, Lipoid Congenital Adrenal Hyperplasia (LCAH) is a rare genetic condition where the body cannot move cholesterol to the right place to turn it into vital hormones [4][5].

To understand this, it helps to think of cholesterol as the “raw material” the body needs to build hormones. In a child with STAR deficiency, the “transport truck” (a protein called StAR) is missing or not working correctly [4]. Because the cholesterol cannot get inside the “factory” (the mitochondria of the cells), the body cannot produce the hormones necessary for regulating salt, sugar, and physical development [5][6].

Because the “raw material” (cholesterol) stays stuck outside the factory, it builds up as fat (lipids) in the adrenal glands, which is why the condition is called “lipoid” [5][6].

An Exceptionally Rare Path

If you feel like you have never heard of this condition, or that your local doctors are unfamiliar with it, you are not alone. LCAH is one of the rarest forms of Congenital Adrenal Hyperplasia (CAH) [7].

  • Global Rarity: The condition is so rare that there are no definitive worldwide numbers, though one major 2023 systematic review identified 292 reported cases globally in the medical literature [8][9]. Case-report totals do not establish current prevalence, but they highlight its rarity.
  • Regional Clusters: It is more frequently diagnosed in East Asian populations (specifically Japan and Korea) due to specific genetic “founder effects,” but it can affect children of any ethnic background [8][10].
  • Genetics: STAR deficiency is an autosomal-recessive condition. When both biological parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of inheriting neither familial variant. A genetic counselor can interpret your actual family result.
  • Medical Knowledge: Because a typical pediatrician may never see a case in their entire career, we strongly recommend requesting that your local providers coordinate directly with a specialist rare-disease endocrinology center to manage your child’s care, rather than relying on you to teach them [3].

Validating Your Experience

The path to a diagnosis for STAR deficiency is rarely a straight line. Many families experience a “diagnostic odyssey” because the symptoms—such as vomiting, poor growth, or salt imbalances—look like many other, more common conditions [1][11].

Furthermore, LCAH can affect how a child’s body looks on the outside in ways that don’t always match their internal genetics (their karyotype) [3][12]. For example, an infant with 46,XY chromosomes may be born with typical female external genital appearance [1]. Learning this information at the same time as an adrenal diagnosis can feel overwhelming. It is normal to feel:

  • Grief for the “typical” health journey you expected for your child.
  • Anxiety about the lifelong nature of hormone replacement.
  • Isolation, as few people in your personal circle will understand the specific challenges of a rare disease.

Looking Forward

While the diagnosis is lifelong, the goal of treatment is to allow your child to live a full, active life. Modern medicine provides the exact hormones the body is unable to make itself [13][14].

In the coming days, your focus will shift from the shock of the diagnosis to the “new normal” of daily management. Your care team will guide you through the specifics of monitoring growth and hormone levels, ensuring your child has everything they need to thrive [13][15]. You do not have to become an expert overnight, but by asking questions and seeking out specialized centers, you are already becoming the advocate your child needs.

Common questions in this guide

What is STAR deficiency, and what does it do to a child's body?
STAR deficiency is a rare inherited form of congenital lipoid adrenal hyperplasia. The StAR protein normally moves cholesterol into the parts of cells where hormones are made; when it is missing or faulty, the body cannot produce enough hormones to regulate salt, blood sugar, and physical development.
How do children inherit STAR deficiency?
STAR deficiency follows an autosomal-recessive pattern, meaning a child usually inherits a nonworking STAR gene copy from each biological parent. When both parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of inheriting neither familial variant. A genetic counselor can explain the family's specific results.
What symptoms can lead to a STAR deficiency diagnosis?
Vomiting, poor growth, and salt imbalances may prompt evaluation, but these signs can resemble more common conditions and may delay diagnosis. The condition can also affect genital development, so a child's external appearance may not always match their chromosome pattern. A pediatric endocrinology team can interpret the findings together.
What does a 46,XY karyotype mean in STAR deficiency?
A karyotype describes a child's chromosome pattern; 46,XY identifies a specific chromosome pattern. In STAR deficiency, impaired hormone production can cause external genital appearance to differ from what is typically expected, including a typically female appearance in some infants with 46,XY chromosomes. The care team and genetic counselor can explain what the result means for the individual child.
How is congenital lipoid adrenal hyperplasia treated?
Treatment replaces the hormones the body cannot make on its own. Care commonly includes lifelong hormone replacement, regular monitoring of growth and hormone levels, and coordination with a pediatric endocrinology or rare-disease center. The goal is to support health, development, and an active life.
Can a child with STAR deficiency live an active life?
STAR deficiency is lifelong, but it is manageable with an individualized care plan and consistent hormone replacement. Regular monitoring and support from a specialized endocrine team can help a child grow and develop and pursue a full, active life.

Get notified when new evidence is published on Congenital lipoid adrenal hyperplasia due to STAR deficency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    [Clinical and StAR genetic characteristics of 33 children with congenital lipoid adrenal hyperplasia].

    Zheng WQ, Duan Y, Xiao B, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2022; (60(10)):1066-1071 doi:10.3760/cma.j.cn112140-20220322-00233.

    PMID: 36207855
  2. 2

    A rare cause of primary adrenal insufficiency due to a homozygous Arg188Cys mutation in the STAR gene.

    Burget L, Parera LA, Fernandez-Cancio M, et al.

    Endocrinology, diabetes & metabolism case reports 2018; (2018()) doi:10.1530/EDM-18-0003.

    PMID: 29576868
  3. 3

    Two Girls With Adrenal Insufficiency and Failing Gonads.

    Poon SW, Li RH, Tung JY

    JCEM case reports 2023; (1(3)):luad044 doi:10.1210/jcemcr/luad044.

    PMID: 37908564
  4. 4

    The Steroidogenic Acute Regulatory (STAR) Gene Anatomy, Expression, and Roles.

    Lim JH, Cheon YP

    Development & reproduction 2025; (29(3)):63-80 doi:10.12717/DR.2025.29.3.63.

    PMID: 41103362
  5. 5

    Clinical spectrum of human STAR variants and their genotype-phenotype correlation.

    Altinkilic EM, Augsburger P, Pandey AV, Flück CE

    The Journal of endocrinology 2024; (262(3)).

    PMID: 38913505
  6. 6

    Disorders in the initial steps of steroid hormone synthesis.

    Miller WL

    The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):18-37 doi:10.1016/j.jsbmb.2016.03.009.

    PMID: 26960203
  7. 7

    Lipoid congenital adrenal hyperplasia by steroidogenic acute regulatory protein (STAR) gene mutation in an Italian infant: an uncommon cause of adrenal insufficiency.

    Bizzarri C, Pisaneschi E, Mucciolo M, et al.

    Italian journal of pediatrics 2017; (43(1)):57 doi:10.1186/s13052-017-0371-y.

    PMID: 28637490
  8. 8

    Steroidogenic acute regulatory protein (STAR) deficiency: Our experience and systematic review for phenotype-genotype correlation.

    Phadte A, Dhole C, Hegishte S, et al.

    Clinical endocrinology 2024; (100(5)):431-440 doi:10.1111/cen.15032.

    PMID: 38368602
  9. 9

    Clinical Features of 57 Patients with Lipoid Congenital Adrenal Hyperplasia: Criteria for Nonclassic Form Revisited.

    Ishii T, Tajima T, Kashimada K, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(11)) doi:10.1210/clinem/dgaa557.

    PMID: 32835366
  10. 10

    Mutation Spectrum of STAR and a Founder Effect of the p.Q258* in Korean Patients with Congenital Lipoid Adrenal Hyperplasia.

    Kang E, Kim YM, Kim GH, et al.

    Molecular medicine (Cambridge, Mass.) 2017; (23()):149-154 doi:10.2119/molmed.2017.00023.

    PMID: 28467518
  11. 11

    Primary Adrenocortical Insufficiency Case Series in the Neonatal Period: Genetic Etiologies Are More Common Than Expected.

    Gao J, Chen L

    Frontiers in pediatrics 2020; (8()):464 doi:10.3389/fped.2020.00464.

    PMID: 32903448
  12. 12

    Clinical characteristics of a male child with non-classic lipoid congenital adrenal hyperplasia and literature review.

    Lu W, Zhang T, Zhang L, et al.

    Frontiers in endocrinology 2022; (13()):947762 doi:10.3389/fendo.2022.947762.

    PMID: 36407315
  13. 13

    Treatment and Follow-up of Non-stress Adrenal Insufficiency

    Buğrul F, Özcan Murat N

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):93-101 doi:10.4274/jcrpe.galenos.2024.2024-6-23-S.

    PMID: 39713906
  14. 14

    Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

    Bornstein SR, Allolio B, Arlt W, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(2)):364-89 doi:10.1210/jc.2015-1710.

    PMID: 26760044
  15. 15

    Two siblings with lipoid congenital adrenal hyperplasia: first reported case in Serbia and literature review.

    Jesic MD, Kovacevic S, Zdravkovic V, et al.

    Frontiers in endocrinology 2026; (17()):1912249 doi:10.3389/fendo.2026.1912249.

    PMID: 42688021

This page is for informational purposes only and does not constitute medical advice about your child's STAR deficiency. Your child's pediatric endocrinology and genetics team should interpret results and guide treatment.